Impact of moderate functional mitral insufficiency in patients undergoing surgical revascularization

Eugene A Grossi1, Gregory A Crooke, Paul L DiGiorgi

  • 1Department of Cardiothoracic Surgery, New York University School of Medicine, New York, NY 10028, USA. grossi@cv.med.nyu.edu

Circulation
|July 6, 2006
PubMed
Abstract

Insights

Mild and moderate mitral regurgitation (MR) significantly decrease survival after coronary artery bypass grafting (CABG), irrespective of left ventricular function. Further research is needed to determine if correcting MR during CABG improves outcomes.

Area of Science:

  • Cardiovascular Surgery
  • Cardiac Surgery Outcomes
  • Mitral Valve Disease

Background:

  • Functional mitral regurgitation (MR) in patients undergoing coronary artery bypass grafting (CABG) presents clinical uncertainty regarding outcomes.
  • The impact of mild to moderate MR versus left ventricular dysfunction on outcomes is not well understood.

Purpose of the Study:

  • To examine early and late outcomes in patients with less-than-severe functional mitral regurgitation undergoing isolated CABG.

Main Methods:

  • Prospective data collection from 2242 patients undergoing isolated CABG (1996-2004) with intraoperative transesophageal echocardiography.
  • Quantification of mitral regurgitation (MR) and ejection fraction (EF); long-term survival assessed via Social Security Death Benefit Index.

Main Results:

  • 37.5% had no MR, 50.7% mild MR, and 11.8% moderate MR.
  • Moderate MR patients were older, more likely female, with higher rates of renal disease, prior myocardial infarction, congestive heart failure, and lower EFs.
  • Decreased survival was independently associated with moderate MR (expbeta=1.49; P=0.007) and mild MR (expbeta=1.34; P=0.033), independent of ventricular function.

Conclusions:

  • Mild and moderate functional mitral regurgitation are independent predictors of decreased survival following CABG.
  • The benefit of correcting moderate functional MR during CABG requires further investigation.

Related Concept Videos

Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...